Cargando…
Evaluation of glycoprotein E subunit and live attenuated varicella‐zoster virus vaccines formulated with a single‐strand RNA‐based adjuvant
INTRODUCTION: Varicella‐zoster virus (VZV), a human alphaherpesvirus 3, elicits both chickenpox and shingles and/or postherpetic neuralgia. A live attenuated vaccine (LAV) and glycoprotein E (gE) subunit vaccine were developed to prevent VZV‐induced diseases. We recently reported that single‐strand...
Autores principales: | Lee, Su Jeen, Park, Hyo‐Jung, Ko, Hae Li, Lee, Jung Eun, Lee, Hyun Joo, Kim, Hun, Nam, Jae‐Hwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212201/ https://www.ncbi.nlm.nih.gov/pubmed/32167678 http://dx.doi.org/10.1002/iid3.297 |
Ejemplares similares
-
Immunogenicity of Varicella-Zoster Virus Glycoprotein E Formulated with Lipid Nanoparticles and Nucleic Immunostimulators in Mice
por: Cao, Han, et al.
Publicado: (2021) -
Seroepidemiology of Varicella-Zoster Virus in Korea
por: Lee, Hyunju, et al.
Publicado: (2013) -
Processing of virus-specific glycoproteins of varicella zoster virus
por: Namazue, Junko, et al.
Publicado: (1985) -
Vernet Syndrome by Varicella-Zoster Virus
por: Jo, Yil Ryun, et al.
Publicado: (2013) -
Varicella zoster virus-associated Chorioretinitis: a case report
por: Kim, Joo Yeon, et al.
Publicado: (2018)